Millions of patients with incurable breast cancer could benefit from Welsh-led research which shows it is possible to control the cancer for twice as long by combing an investigational therapy with standard treatment.
Jun 10, 2019
0
3
A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help premenopausal women with the most common type of breast cancer live longer than if they only receive the ...
Jun 03, 2019
1
2
Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.
Jun 03, 2019
0
9
(HealthDay)—Clinical guidelines on adjuvant and salvage radiotherapy after radical prostatectomy have been updated, according to the American Society for Radiation Oncology and the American Urological Association.
May 31, 2019
0
2
New research confirms that an algorithm, called CTS5, can accurately identify patients who are at a significantly low risk of their breast cancer returning at a later stage. In doing so it means some patients may need to ...
May 31, 2019
0
1
Although hormone therapy (HT) is the most commonly recommended treatment for menopause symptoms, research is ongoing for alternatives, especially nonpharmacologic options. Cognitive behavior therapy has previously been proposed ...
May 29, 2019
0
1
Nearly all women who have been treated for non-metastatic breast cancer suffer from health problems after primary treatment. The problems reported by women include fatigue, tingling in the hands and feet (neuropathy), and ...
May 20, 2019
0
3
Transgender women (male sex assigned at birth, female gender identity) using hormone treatment show an increased risk of breast cancer compared with the general male population, finds a large Dutch study published by The ...
May 14, 2019
0
21
For women depending on steroids to treat severe asthma, their body's estrogen may not only be preventing the treatment from working effectively, but making the asthma worse, according to a recent Western study.
May 09, 2019
0
1
Researchers at Karolinska Institutet in Sweden have identified blood-based biomarkers that may determine which patients will benefit from continued hormonal therapy for advanced prostate cancer. The results are published ...
May 03, 2019
0
68
